Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo.

  title={Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo.},
  author={Arthur S. Walters and Mary L. Wagner and W. Hening and Kenneth W. Grasing and Richard Mills and Sudhansu Chokroverty and Neil Kavey},
  volume={16 4},
In a double-blind randomized crossover trial, oxycodone or placebo was given in divided night-time doses to 11 patients with idiopathic restless legs syndrome (RLS) for 2 weeks prior to appropriate polysomnographic studies. Under double-blinded conditions, patients were asked to do daily ratings of their leg sensations, motor restlessness and daytime alertness on a 1-4 scale for the 2 weeks prior to the polysomnographic studies and for the nights of the polysomnographic studies as well. Leg… 
Movements and Sleep Randomized, Double-Blind, Placebo-Controlled Study of Clonidine in Restless Legs Syndrome
Clonidine may be an effective treatment for RLS patients who don't have large numbers of sleep-disrupting periodic limb movements but have delayed sleep onset due to leg sensations and subsequent motor restlessness.
A Randomized, Double-Blind Placebo-Controlled Trial of Iron in Restless Legs Syndrome
Iron sulfate does not appear to be an effective empiric treatment for restless legs syndrome and should not be considered as a treatment for insomnia.
L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.
It is concluded that L-dopa 100-200 mg proved to be effective in idiopathic RLS and for the first time under controlled conditions in uremic R LS without any severe side effects.
Pneumatic compression devices are an effective therapy for restless legs syndrome: a prospective, randomized, double-blinded, sham-controlled trial.
PCDs resulted in clinically significant improvements in symptoms of RLS in comparison to the use of sham devices and may be an effective adjunctive or alternative therapy for RLS.
Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension
OXN PR improved RLS symptom severity and sleep quantity and adequacy, resulting in greater sleep satisfaction, less daytime tiredness, and improved QoL and should be considered as an alternative treatment option for severe RLS that cannot be controlled by first-line dopaminergic medications.
Efficacy of pergolide in treatment of restless legs syndrome
Pergolide substantially improves periodic limb movement measures and subjective sleep disturbance associated with restless legs syndrome and exhibited marked improvements in these measures that were maintained at 12 months.
Movements During Sleep L-Dopa Therapy of Uremic and Idiopathic Restless Legs Syndrome: A Double-Blind, Crossover Trial
Summary: We report the effects of a single bedtime dose of L-dopa 100-200 mg on sleep quality, frequency of periodic leg movements (PLM) and daily living in patients with idiopathic and uremic
Efficacy of cabergoline in restless legs syndrome
Single-evening cabergoline is an efficacious and well-tolerated short-term therapy for sensorimotor symptoms of restless legs syndrome and associated sleep disturbances.
The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials
This post hoc pooled analysis suggests that GEn (600 and 1200 mg) once daily significantly improved pain associated with moderate-to-severe primary RLS in adults; however, the analysis was not powered to detect statistical differences between the two GEn doses.